NIH Image Gallery from Bethesda, Maryland, USA, Public domain, via Wikimedia Commons

NIH Image Gallery from Bethesda, Maryland, USA, Public domain, via Wikimedia Commons


Anthony S. Fauci, MD, who was instrumental in leading the country through the COVID-19 pandemic, announced today through a statement from the National Institutes of Health (NIH) that he is stepping down from the positions of Director of the National Institute of Allergy and Infections Diseases (NIAID) and Chief of the NIAID Laboratory of Immunoregulation, as well as the position of Chief Medical Advisor to President Joe Biden, effective in December of this year to pursue the next chapter of his career. 

Fauci stated in the release:

"It has been the honor of a lifetime to have led the NIAID, an extraordinary institution, for so many years and through so many scientific and public health challenges. I am very proud of our many accomplishments. I have worked with — and learned from — countless talented and dedicated people in my own laboratory, at NIAID, at NIH and beyond. To them I express my abiding respect and gratitude.

"Over the past 38 years as NIAID Director, I have had the enormous privilege of serving under and advising seven Presidents of the United States, beginning with President Ronald Reagan, on newly emerging and re-emerging infectious disease threats including HIV/AIDS, West Nile virus, the anthrax attacks, pandemic influenza, various bird influenza threats, Ebola and Zika, among others, and, of course, most recently the COVID-19 pandemic. I am particularly proud to have served as the Chief Medical Advisor to President Joe Biden since the very first day of his administration.

"While I am moving on from my current positions, I am not retiring. After more than 50 years of government service, I plan to pursue the next phase of my career while I still have so much energy and passion for my field. I want to use what I have learned as NIAID Director to continue to advance science and public health and to inspire and mentor the next generation of scientific leaders as they help prepare the world to face future infectious disease threats.

"Over the coming months, I will continue to put my full effort, passion and commitment into my current responsibilities, as well as help prepare the Institute for a leadership transition. NIH is served by some of the most talented scientists in the world, and I have no doubt that I am leaving this work in very capable hands.

"Thanks to the power of science and investments in research and innovation, the world has been able to fight deadly diseases and help save lives around the globe. I am proud to have been part of this important work and look forward to helping to continue to do so in the future."

For more information: www.nih.gov

Related Long-COVID Content: 

MRI Sheds Light on COVID Vaccine-Associated Heart Muscle Injury 

What We Know About Cardiac Long-COVID Two Years Into the Pandemic  

VIDEO: Long-term Cardiac Impacts of COVID-19 Two Years Into The Pandemic — Interview with Aaron Baggish, M.D. 

VIDEO: Long-COVID Presentations in Cardiology at Beaumont Hospital — Interview with Justin Trivax, M.D. 

VIDEO: Cardiac Presentations in COVID Long-haulers at Cedars-Sinai Hospital — Interview with Siddharth Singh, M.D. 

Find more COVID news and videos 

Related COVID Content: 

COVID-19 Fallout May Lead to More Cancer Deaths 

Kawasaki-like Inflammatory Disease Affects Children With COVID-19 

FDA Adds Myocarditis Warning to COVID mRNA Vaccine Clinician Fact Sheets 

CMS Now Requires COVID-19 Vaccinations for Healthcare Workers by January 4 

Cardiac MRI of Myocarditis After COVID-19 Vaccination in Adolescents 

Small Number of Patients Have Myocarditis-like Illness After COVID-19 Vaccination 

Overview of Myocarditis Cases Caused by the COVID-19 Vaccine 

Case Study Describes One of the First U.S. Cases of MIS-C 

NIH-funded Project Wants to Identify Children at Risk for MIS-C From COVID-19 


Related Content

News | RSNA

November 30, 2022 — Findings from four separate studies on long-term impacts of COVID-19 were presented during a ...

Time November 30, 2022
arrow
News | RSNA

November 28, 2022 — Adam E. Flanders, M.D., FSIIM, a prolific mentor, author and pioneer for digital learning, was ...

Time November 28, 2022
arrow
News | RSNA | By Christine Book

November 27, 2022 — Among dozens of technical exhibit visits, informative discussions, and captivating Plenary Session ...

Time November 27, 2022
arrow
News | RSNA

November 23, 2022 — With the aim of cultivating global partnerships and improving health equity, access, safety and ...

Time November 23, 2022
arrow
News | RSNA

Updated November 29, 2022 — The Radiological Society of North America (RSNA) has announced the official results of the ...

Time November 23, 2022
arrow
News | Magnetic Resonance Imaging (MRI)

November 21, 2022 — Using a special type of MRI, researchers have uncovered brain changes in patients up to six months ...

Time November 21, 2022
arrow
Feature | RSNA | By Alan Stoddart

Top 10 Predictions for RSNA 2022 was published as an infographic as part of Signify Research's Premium Insights service ...

Time November 17, 2022
arrow
News | Digital Pathology

November 9, 2022 — GE Healthcare and Tribun Health have entered a collaboration with the intent to provide digital ...

Time November 09, 2022
arrow
News | ACR

November 8, 2022 — The American College of Radiology (ACR) is urging screening centers across the country to “open doors ...

Time November 08, 2022
arrow
Feature | Radiology Business | By Melinda Taschetta-Millane

Here is a rundown of what you and your colleagues found to be most interesting in the field of medical imaging during ...

Time November 01, 2022
arrow
Subscribe Now